MD2551G2 - Utilizarea soluţiilor ozonate acceptabile farmaceutic ozonate pentru tratamentul micozelor cavităţii bucale - Google Patents

Utilizarea soluţiilor ozonate acceptabile farmaceutic ozonate pentru tratamentul micozelor cavităţii bucale

Info

Publication number
MD2551G2
MD2551G2 MDA20030280A MD20030280A MD2551G2 MD 2551 G2 MD2551 G2 MD 2551G2 MD A20030280 A MDA20030280 A MD A20030280A MD 20030280 A MD20030280 A MD 20030280A MD 2551 G2 MD2551 G2 MD 2551G2
Authority
MD
Moldova
Prior art keywords
mycoses
treatment
pharmaceutically acceptable
oral cavity
ozonized
Prior art date
Application number
MDA20030280A
Other languages
English (en)
Russian (ru)
Inventor
Андрей ПЫРГАРЬ
Борис ПЫРГАРЬ
Original Assignee
Андрей ПЫРГАРЬ
Борис ПЫРГАРЬ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Андрей ПЫРГАРЬ, Борис ПЫРГАРЬ filed Critical Андрей ПЫРГАРЬ
Priority to MDA20030280A priority Critical patent/MD2551G2/ro
Publication of MD2551G2 publication Critical patent/MD2551G2/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la medicină, în special la stomatologie.Esenţa invenţiei constă în utilizarea soluţiilor acceptabile farmaceutic ozonate pentru tratamentul micozelor cavităţii bucale.
MDA20030280A 2003-12-03 2003-12-03 Utilizarea soluţiilor ozonate acceptabile farmaceutic ozonate pentru tratamentul micozelor cavităţii bucale MD2551G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030280A MD2551G2 (ro) 2003-12-03 2003-12-03 Utilizarea soluţiilor ozonate acceptabile farmaceutic ozonate pentru tratamentul micozelor cavităţii bucale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030280A MD2551G2 (ro) 2003-12-03 2003-12-03 Utilizarea soluţiilor ozonate acceptabile farmaceutic ozonate pentru tratamentul micozelor cavităţii bucale

Publications (1)

Publication Number Publication Date
MD2551G2 true MD2551G2 (ro) 2005-03-31

Family

ID=62129620

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030280A MD2551G2 (ro) 2003-12-03 2003-12-03 Utilizarea soluţiilor ozonate acceptabile farmaceutic ozonate pentru tratamentul micozelor cavităţii bucale

Country Status (1)

Country Link
MD (1) MD2551G2 (ro)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2123319C1 (ru) * 1996-12-24 1998-12-20 Нижегородская государственная медицинская академия Способ лечения воспалительных заболеваний пародонта
MD2354F1 (ro) * 2003-07-29 2004-01-31 Boris Pirgari Metoda de tratament al encefalopatiei hepatice
MD2375F1 (ro) * 2003-07-29 2004-02-29 Constantin Tibirna Metoda de tratament al gastropatiei portale in ciroza hepatica
MD2327G2 (ro) * 2003-07-11 2004-07-31 Андрей ПЫРГАРЬ Metodă de tratament al afecţiunilor parodonţiului

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2123319C1 (ru) * 1996-12-24 1998-12-20 Нижегородская государственная медицинская академия Способ лечения воспалительных заболеваний пародонта
MD2327G2 (ro) * 2003-07-11 2004-07-31 Андрей ПЫРГАРЬ Metodă de tratament al afecţiunilor parodonţiului
MD2354F1 (ro) * 2003-07-29 2004-01-31 Boris Pirgari Metoda de tratament al encefalopatiei hepatice
MD2375F1 (ro) * 2003-07-29 2004-02-29 Constantin Tibirna Metoda de tratament al gastropatiei portale in ciroza hepatica

Similar Documents

Publication Publication Date Title
YU30004A (sh) Upotreba flibanserina u lečenju seksualnih poremećaja
ZA200606173B (en) Effervescent oral opiate dosage form
TW200505881A (en) Tri(cyclo) substituted amide compounds
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
TW200500358A (en) Compounds
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
HRP20041092A2 (en) New pharmaceutical compositions containing filbanserin polymorph a
IL175303A0 (en) Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
AU2003272317A1 (en) Treatment of periodontal disease with photosensitizers
GR20020100478A (el) Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
MXPA05014184A (es) Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral.
UA85685C2 (ru) Применение хинолоновых антибиотиков для лечения бактериальных заболеваний ротовой полости
RS20050835A (en) Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
EG24959A (en) Indoles useful in the treatment of androgenreceptor related diseases.
MD2551G2 (ro) Utilizarea soluţiilor ozonate acceptabile farmaceutic ozonate pentru tratamentul micozelor cavităţii bucale
MXPA05007253A (es) Sales novedosas de derivados anticonvulsivantes.
PL371269A1 (en) 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
UA90843C2 (ru) Соединения три(цикло)-замещенных амидов

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees